Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ashraf Fathy Barakat"'
Autor:
Sara Adel Amin, Emad Abd El Mongy Sadaka, Khalid Ahmed Ismail, Ashraf Fathy Barakat, Ahmed Abdel Aziem Menaisy, Amr Abd Elmoneim Mahmoud
Publikováno v:
Journal of the Pakistan Medical Association, Vol 73, Iss 4 (2023)
Objective: To examine the C-X-C Motif Chemokine Receptor 1 expression in breast cancer tissues prior to neo-adjuvant chemotherapy, and its relationship to neo-adjuvant chemotherapy effectiveness and other prognostic variables. Method: The prospective
Externí odkaz:
https://doaj.org/article/539742db16874b6fb06b9957c25b39f7
Autor:
Sara Adel Amin, Emad Abd El Mongy Sadaka, Khalid Ahmed Ismail, Ashraf Fathy Barakat, Ahmed Abdel Aziem Menaisy, Amr Abd Elmoneim Mahmoud
Publikováno v:
Journal of the Pakistan Medical Association, Vol 73, Iss 4 (2023)
Objective: To examine the chemokine receptor type 1 expression in breast cancer tissues before and after neoadjuvant chemotherapy, and its relationship with pathological response to neoadjuvant chemotherapy and other clinical variables. Methods: The
Externí odkaz:
https://doaj.org/article/a8f5b2362fc74165addd489afc94092c
Autor:
Ashraf fathy Barakat, Fatma Zakaria Hussein, Wael Mansour Saed, Sally Hamdy Elsied Abd Elbary
Publikováno v:
Journal of Advances in Medicine and Medical Research. :43-53
Background: Two chemotherapeutic agents, vinorelbine and gemcitabine, have shown encouraging early results in the treatment of heavily pre-treated relapsed or refractory lymphoma when used as single agents, with responses of between 20 and 47%. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7269b2f36d3a0083a843e84e7324c523
https://doi.org/10.9734/jammr/2021/v33i2331184
https://doi.org/10.9734/jammr/2021/v33i2331184
Autor:
Ashraf Fathy Barakat, Bassant Mahmoud Dawoud, Khalid Abd El-Wehab Abo Dewan, Reda Ahmed Abd Elsamie Elarabawy
Publikováno v:
Zagazig University Medical Journal. 24:501-511
Objectives : To describe the diagnostic performance of dynamic contrast enhanced MRI in differentiating between benign and malignant breast lesions. Methods: the study was conducted on 40 patients with 40 lesions. MR examinations were performed using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::addb288d43cc6d3c9072685d183c0410
https://doi.org/10.21608/zumj.2018.18291
https://doi.org/10.21608/zumj.2018.18291